ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 210 filers reported holding ARGENX SE in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $778 | -99.9% | 1,584 | -38.2% | 0.03% | -16.7% |
Q2 2023 | $998,878 | +100898.8% | 2,563 | -3.4% | 0.04% | -5.3% |
Q1 2023 | $989 | -1.6% | 2,654 | 0.0% | 0.04% | -5.0% |
Q4 2022 | $1,005 | -99.8% | 2,654 | +69.2% | 0.04% | +66.7% |
Q3 2022 | $554,000 | -6.7% | 1,569 | 0.0% | 0.02% | 0.0% |
Q2 2022 | $594,000 | +1.4% | 1,569 | -19.1% | 0.02% | +33.3% |
Q3 2021 | $586,000 | +0.3% | 1,939 | 0.0% | 0.02% | +5.9% |
Q2 2021 | $584,000 | +9.4% | 1,939 | 0.0% | 0.02% | +6.2% |
Q1 2021 | $534,000 | – | 1,939 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |